Seven area startups selected for Upstate Medical’s medical device innovation challenge

SYRACUSE, N.Y. — Upstate Medical University announced it has selected seven startups with medical devices and service proposals to participate in what’s being called the “medical device innovation challenge.”

Upstate MIND is sponsoring the program at the Central New York Biotech Accelerator (CNYBAC) at Upstate Medical University. The CNYBAC is located at 841 E. Fayette St. in Syracuse.

MIND is short for “medical innovation and novel discovery center,” Upstate said in a news release issued Tuesday.

[elementor-template id="66015"]

The devices and service proposals include a heat sleeve designed for limb amputees, an at-home glaucoma measurement test, and a personal health and wellness messaging system.

Upstate Medical on Wednesday held a reception in the CNYBAC for those startups that will participate in the program.

Participants in the “medical device innovation challenge” get six months of rent-free space at the CNYBAC and use of the Upstate MIND “creation garage,” a space equipped with technology, such as 3D printers, to go from idea to prototype.

Advertisement

The program will also provide free consultations with business experts on how to pitch their products to gain further funding, navigate the regulatory environment, and produce data to help assess product marketability.

Additionally, the winners also get free admittance to business-related workshops, including the upcoming medical device concept-to-commercialization boot camp, Upstate Medical said.

“We anticipate that at the end of the program, these start-ups will have determined if their medical device products or services have the commercialized viability, plans and prototype to move into the commercialization stage,” Robert Corona, VP for innovation and business development at the CNYBAC, said in the Upstate news release.

Participating startups

The startups include Costello Prosthetic Warmers, a medical-device startup founded by Bryan Costello, a lower-leg amputee who invented its first product, the Costello Heatsleeve.

Another startup is EndoGlow, which designs and manufactures fluorescent medical devices for use in surgery and other procedures.

Advertisement

In addition, ISEE Loyal Tech is a startup that seeks to design, patent, and market ophthalmological devices that make a “meaningful difference” in a patient’s life.

ISEE ‘s primary focus is in the area of glaucoma prevention and treatment, Upstate said.

The startups also include ModoScript, which is working on its pill-safe system, which is a business-to-business platform for physicians, health-insurance providers, pharmaceutical companies, health-care facilities, government agencies, and law enforcement.

One Stone Technology LLC is seeking options to support “sustained behavior modification to improve health and wellness.” One product is a patient engagement/messaging platform that supports “direct communication” between patients and subscribers and their clinical team or health coach.

 Harris Skeele Corp., which is also known as Simpler Links, is a medical-device startup founded by two nurses with a focus on contributing to the reduction of “catheter associated urinary tract infections” or CAUTIs.

Finally, Superlative BioSciences Corp. is a biosciences product and service company. It plans to “develop, validate, and market” its stem cellular toxicology service – a system of medical device in vitro diagnostics in the field of human-developmental toxicology that uses human umbilical cord and placental stem cells in tissue culture instead of animals.

Advertisement

 

Contact Reinhardt at ereinhardt@cnybj.com

 

PHOTO CAPTION: Upstate MIND is sponsoring the “medical device innovation challenge” at the Central New York Biotech Accelerator (CNYBAC) at Upstate Medical University. The CNYBAC is located at 841 E. Fayette St. in Syracuse. Seven startups with medical devices and service proposals will participate in the program. MIND is short for “medical innovation and novel discovery center,” Upstate said in a news release issued Tuesday. (Eric Reinhardt / BJNN file photo)

 

 

 

Eric Reinhardt: